Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection
PHASE3CompletedINTERVENTIONAL
Enrollment
100
Participants
Timeline
Start Date
August 31, 2001
Study Completion Date
October 31, 2004
Conditions
HIV InfectionsChronic Hepatitis B
Interventions
DRUG
Adefovir Dipivoxil
Trial Locations (1)
20892
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00023153 - Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection | Biotech Hunter | Biotech Hunter